The Defense Health Agency awarded a $564,698 Project Grant to Texas A&M Engineering Experiment Station (Tees) under the Military Medical Research and Development program (CFDA 12.420) to develop "Engineered Therapeutic Extracellular Vesicles to Resolve Pyridostigmine Bromide-Induced Enteric Neuroinflammation in Gulf War Illness." The grant runs from November 1, 2024 to October 31, 2027.
Tees has subcontracted a portion of the work to The Ohio State University, who will receive $500,125 to support the development of the engineered extracellular vesicles. This Project Grant aims to advance innovative biomedical research to improve health outcomes for military service members, veterans, and the broader public by investigating treatments for conditions like Gulf War Illness.
Generated 3/4/25, 7:57 AM